Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

A molecular link between the active component of marijuana and Alzheimer's disease pathology.

Eubanks LM, Rogers CJ, Beuscher AE 4th, Koob GF, Olson AJ, Dickerson TJ, Janda KD.

Mol Pharm. 2006 Nov-Dec;3(6):773-7.

PMID:
17140265
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P.

N Engl J Med. 2012 Mar 8;366(10):893-903. doi: 10.1056/NEJMoa1106668.

PMID:
22397651
[PubMed - indexed for MEDLINE]
Free Article
3.

ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale)--validation of the Slovak version.

Kolibas E, Korinkova V, Novotny V, Vajdickova K, Hunakova D.

Bratisl Lek Listy. 2000;101(11):598-602.

PMID:
11218956
[PubMed - indexed for MEDLINE]
4.

Cholinesterase inhibitors for Alzheimer's disease.

Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Review.

PMID:
16437532
[PubMed - indexed for MEDLINE]
5.

Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.

Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, Boscolo FS, Carson CT, Laurent LC, Marsala M, Gage FH, Remes AM, Koo EH, Goldstein LS.

Nature. 2012 Jan 25;482(7384):216-20. doi: 10.1038/nature10821.

PMID:
22278060
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Diet and Alzheimer's disease risk factors or prevention: the current evidence.

Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A.

Expert Rev Neurother. 2011 May;11(5):677-708. doi: 10.1586/ern.11.56. Review.

PMID:
21539488
[PubMed - indexed for MEDLINE]
7.

Solanezumab for the treatment of mild-to-moderate Alzheimer's disease.

Imbimbo BP, Ottonello S, Frisardi V, Solfrizzi V, Greco A, Seripa D, Pilotto A, Panza F.

Expert Rev Clin Immunol. 2012 Feb;8(2):135-49. doi: 10.1586/eci.11.93. Review.

PMID:
22288451
[PubMed - indexed for MEDLINE]
8.

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Hardy J, Selkoe DJ.

Science. 2002 Jul 19;297(5580):353-6. Review. Erratum in: Science 2002 Sep 27;297(5590):2209.

PMID:
12130773
[PubMed - indexed for MEDLINE]
9.

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH.

Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.

PMID:
21514250
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities.

Cummings JL, Vinters HV, Cole GM, Khachaturian ZS.

Neurology. 1998 Jul;51(1 Suppl 1):S2-17; discussion S65-7. Review.

PMID:
9674758
[PubMed - indexed for MEDLINE]
11.

A review: inflammatory process in Alzheimer's disease, role of cytokines.

Rubio-Perez JM, Morillas-Ruiz JM.

ScientificWorldJournal. 2012;2012:756357. doi: 10.1100/2012/756357. Epub 2012 Apr 1. Review.

PMID:
22566778
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.

Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jönsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K.

Nature. 2012 Aug 2;488(7409):96-9. doi: 10.1038/nature11283.

PMID:
22801501
[PubMed - indexed for MEDLINE]
13.

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A.

Immunotherapy. 2012 Feb;4(2):213-38. doi: 10.2217/imt.11.170. Review.

PMID:
22339463
[PubMed - indexed for MEDLINE]
14.

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C.

Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210. Review.

PMID:
22541366
[PubMed - indexed for MEDLINE]
Free Article
15.

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.

de la Monte SM.

Curr Alzheimer Res. 2012 Jan;9(1):35-66. Review.

PMID:
22329651
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH.

Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.

PMID:
21514249
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM.

Neurology. 1984 Jul;34(7):939-44.

PMID:
6610841
[PubMed - indexed for MEDLINE]
18.

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC; Dominantly Inherited Alzheimer Network.

N Engl J Med. 2012 Aug 30;367(9):795-804. doi: 10.1056/NEJMoa1202753. Epub 2012 Jul 11. Erratum in: N Engl J Med. 2012 Aug 23;367(8):780.

PMID:
22784036
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.

Martín-Moreno AM, Reigada D, Ramírez BG, Mechoulam R, Innamorato N, Cuadrado A, de Ceballos ML.

Mol Pharmacol. 2011 Jun;79(6):964-73. doi: 10.1124/mol.111.071290. Epub 2011 Feb 24.

PMID:
21350020
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P.

Lancet Neurol. 2007 Aug;6(8):734-46. Review.

PMID:
17616482
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk